Biome Australia Ltd · ASX:BIO

Biome Australia — Investor Presentation (February 2025)

27 slides from Biome Australia's investor presentation, Feb 28, 2025

  1. Slide 1: Updated Company Presentation and Shareholder Webinar Announcement

    ASX ANNOUNCEMENT 28 February 2025 Biome Australia’s Updated Company Presentation and Shareholder Webinar Announcement ● Biome Australia updates its Company Presentation ● Biome Australia schedules webinar for Friday 7th March, 10.00am-10.45am AEDT ● Webinar details and registration link to be shared

  2. Slide 2: Investor Relations and media contacts

    on the newfound systemic health effects of the gut microbiota, helping them to provide innovative, evidence-based natural medicines for the management of some of humanity's most prevalent and chronic health concerns. For more information visit: www.biomeaustralia.com Investor Relations Lauren Caruan

  3. Slide 3: Company Presentation March 2025

    Biome Australia For personal use only March 2025 Company Jan 2024 Strategy Meeting Presentation Blair Vega Norfolk, Founder & Managing Director Company Presentation | March 2025 1

  4. Slide 4: Disclaimer

    Biome Australia Disclaimer For personal use only This presentation and the information contained within it (the This presentation contains forward-looking statements, which may be The recipient must, and agrees with the Company that it will, make its “information”) has been prepared solely for the u

  5. Slide 5: About Biome Australia

    Biome Australia For personal use only About Biome Australia Biome Australia (ASX: BIO) is focused on becoming a global leader in the complementary medicine industry, offering clinically-proven, condition-specific probiotic products fueled by novel clinical research programs to cement and extend the

  6. Slide 6: The Microbiome Health Company

    Biome Australia Group The Microbiome Health Company For personal use only Our mission To prevent disease, improve health outcomes and quality of life, and make our products accessible to all Company Presentation | March 2025 4

  7. Slide 7: The Microbiome Health Company

    Biome Australia Group The Microbiome Health Company For personal use only Company Presentation | March 2025 55

  8. Slide 8: Activated Probiotics Range

    Biome Australia For personal use only 02. Activated Probiotics Range Company Presentation | March 2025 2025 6

  9. Slide 9: Activated Probiotics

    Biome Australia Activated For personal use only Probiotics Practitioners & Pharmacies CONSUMER BENEFITS 5x more effective delivery — MicrobacTM technology Shelf-stable Clinically documented probiotic strains Company Presentation | March 2025 7

  10. Slide 10: Business Highlights

    Biome Australia For personal use only 01. Business Highlights Company Presentation | March March2025 2025 8

  11. Slide 11: Business Highlights

    Biome Australia For personal use only Biome Business Over 6,000 distribution points (Aus) following successful launch with Priceline Pharmacy Highlights Average shopper ~2.5 units per transaction and 6 visits per year in pharmacy (Terry White Scan data) #1 growth Practitioner-Only brand in Australia

  12. Slide 12: Business Highlights

    Biome Australia For personal use only Biome Business 1H25 sales revenue of $8.9m (vs $13m FY24) Highlights EBITDA $122k in Q1 & $230k in Q2, an increases of 89% Net profit of $96,228 (excl R&D rebate) for H1 or $433,395(incl R&D rebate) Retail scan sales for two largest pharmacy groups average over 8

  13. Slide 13: Distribution and Sales Model

    Biome Australia For personal use only 03. Distribution and Sales Model Company Presentation | March 2025 11

  14. Slide 14: Sales Model - Practitioner Only

    Biome Australia Training and Education Driven For personal use only Sales Model - Practitioner Only Unique Education and Service Model Drives Sales in Australia, UK and NZ Education and Service Support • The Biome sales team is a mix of health qualified practitioner education consultants and territo

  15. Slide 15: Vision

    Biome Australia For personal use only 04. Vision 27 Company Presentation March | March 2025 2025 13

  16. Slide 16: Vision: Revenue Growth

    Biome Australia Vision 27 For personal use only Revenue Growth Biome has a three year cumulative sales revenue target of up to $85m. ($75m-$85m for FY25-FY27) ● This represents an increases of 350% on $24m for the three previous years 1. Distribution Growth & Business Development ● Grow the existing

  17. Slide 17: Vision: Supply Chain and New Brand and Product Range

    Biome Australia For personal use only Vision 27 3. Supply Chain Bring Activated Probiotics to the mainstream market as a ● Identification and viability analysis of a novel probiotic strain that is significant probiotic brand locally and abroad. proprietary to Biome ○ Lactobacillus plantarum BMB18 ○ Po

  18. Slide 18: Distribution Growth & Business Development

    Biome Australia For personal use only 03. Distribution Growth & Business Development Company Presentation | March 2025 16

  19. Slide 19: Distribution Growth & Business Development

    Biome Australia Distribution Growth & Business For personal use only Development ● Biome has grown its Australian distribution from 100 distribution points in 2019 to 6000 in 2025 - the total addressable distribution market for Biome in our local market is ~12,000. ● Existing distribution (6000) is

  20. Slide 20: IP Development

    Biome Australia For personal use only 03. IP Development Company Presentation | March 2025 18

  21. Slide 21: BMB18

    Biome Australia For personal use only BMB18 Biome has executed an agreement to develop a Biome owned novel probiotic strain ● Lactobacillus plantarum BMB18 Biome has successfully completed the identification, commercial validation and initial characterisation of the probiotic strain Lactobacillus pla

  22. Slide 22: International Markets

    Biome Australia For personal use only 05. International Markets Company Presentation | March 2025 2025 20

  23. Slide 23: Canada — North America

    Biome Australia For personal use only Canada — North America International markets grow 95% to reach ~$895k in sales revenue for FY24 ● Health Canada Approvals received in H2 FY24 (12/17 Activated Probiotics products) ● Test market launch successful with Ecotrend In Q1 FY25 ● First territory manager

  24. Slide 24: New Product Development

    Biome Australia For personal use only 06. New Product Development Company Presentation | March 2025 22

  25. Slide 25: For personal use only

    Biome Australia Group The Microbiome Health Company For personal use only Company Presentation | March 2025 23

  26. Slide 26: Summary

    Biome Australia For personal use only Summary ● FY24 Sales Revenue $13.01m, up 80% ● FY25 Q1 pharmacy same stores sales up 68% (vs PCP) ● Q2 FY25 Sales Revenue $4.6m (new record) ● Three ongoing clinical trials on key products ● Q2 $229,917 EBITDA adjusted for non-cash, share-based payments) ● Avera

  27. Slide 27: Contact details

    Biome Australia For personal use only Contact details Blair Norfolk, CEO Douglas Loh, CFO Email corporate@biomeaustralia.com Websites biomeaustralia.com activatedprobiotics.com.au Company Presentation | March 2025 25

Biome Australia — Investor Presentation (February 2025) on 6ix